Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach

A number of germ-line mutations in the BRCA1 gene confer susceptibility to breast and ovarian cancer. However, it remains difficult to determine whether many single amino-acid (missense) changes in the BRCA1 protein that are frequently detected in the clinical setting are pathologic or not. Here, we...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Tischkowitz, Marc, Hamel, Nancy, Carvalho, Marcelo A, Birrane, Gabriel, Soni, Aditi, van Beers, Erik H, Joosse, Simon A, Wong, Nora, Novak, David, Quenneville, Louise A, Grist, Scott A, kConFab, Nederlof, Petra M, Goldgar, David E, Tavtigian, Sean V, Monteiro, Alvaro N, Ladias, John AA, Foulkes, William D
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3905962/
https://ncbi.nlm.nih.gov/pubmed/18285836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ejhg.2008.13
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares